• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 11, 2017

Trending News Today: NCI Initiative Seeks to Improve Access to Cancer Drugs

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

The surge in heroin overdoses can largely be attributed to the change in OxyContin, a new study finds. In an effort to curb prescription drug abuse, Purdue Pharma has spent a decade and several hundred million dollars to develop a form of OxyContin that is more difficult to snort, smoke, or inject, according to the Los Angeles Times. Through these efforts, the misuse of painkillers has fallen; however, heroin overdoses have dramatically increased. Experts have placed the blame for the heroin epidemic on painkiller addicts switching to the cheaper and more accessible street opioids, the LA Times reported. Unfortunately, the first large-scale study has tied the dramatic rise in heroin deaths since 2010 to Purdue’s reformulation of OxyContin. In a statement issued by Purdue, they noted that government officials have been urging drug companies to develop abuse-deterrent painkillers, such as the reformulated OxyContin.

In an effort to speed up clinical trials, the National Cancer Institute (NCI) launched an initiative to create a virtual formulary that allows researchers to gain faster access to the drugs they want to test, according to The Washington Post. The virtual formulary will initially include 15 different medications donated by 6 manufacturers, and will allow the institute to act as an intermediary between drug companies and scientists at 69 NCI-designated cancer centers. Furthermore, the program will streamline the process through which researchers obtain the therapies, and will be particularly helpful for scientists who want to test combinations of drugs, the Post reported. Through the new public-private partnership, manufacturers will be held to tighter timelines to decide whether to provide drugs for proposed clinical trials, according to NCI officials. James Doroshow, deputy NCI director for clinical and translational research, said the institute is currently negotiating with a significant number of additional pharmaceutical companies. This could lead to twice the amount of drugs included in the formulary by the end of the year, the Post reported.

On Tuesday, the US Preventive Services Task Force (USPSTF) reiterated its 2009 recommendation that all women who can conceive should take 400 to 800 micrograms of vitamin B per day. Taking 1 pill per day of a folic acid supplement can lower the risk of a certain type of serious birth defect in the future, NPR reported. In 1991, a study found folic acid supplementation greatly reduced the risk of neural defects, including anencephaly and spina bifida. According to the USPSTF, fortification was associated with a drop in neural tube defects, from 10.7 cases per 10,000 life before fortification to 7 cases after fortification. Little evidence has been found of serious harm from folic acid supplementation in women of childbearing age, NPR reported.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 6th 2025

Study Demonstrates Semaglutide Improves Liver Histologic Results in Patients With MASH

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia
May 4th 2025

Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia

Aislinn Antrim, Managing Editor
Hepatitis B therapeutic vaccine -- Image credit: syhin_stas | stock.adobe.com
May 3rd 2025

Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB

Gillian McGovern, Associate Editor
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 6th 2025

Study Demonstrates Semaglutide Improves Liver Histologic Results in Patients With MASH

Gillian McGovern, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia
May 4th 2025

Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia

Aislinn Antrim, Managing Editor
Hepatitis B therapeutic vaccine -- Image credit: syhin_stas | stock.adobe.com
May 3rd 2025

Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB

Gillian McGovern, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.